B

Biogenosis

Europe, Liege, Belgium, Liège

Description

Biogenosis is a biotechnology company.

Investor Profile

Biogenosis has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.

Stage Focus

  • Series B (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biogenosis frequently co-invest with?

Pfizer
North America, New York, United States, New York
Co-Investments: 1
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
KU Leuven
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Epimède
Europe, Liege, Belgium, Liège
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 1
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1

What are some of recent deals done by Biogenosis?

Imcyse

Liège, Liege, Belgium

Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.

BiotechnologyPharmaceuticalTherapeutics
Series BFeb 17, 2021
Amount Raised: $25,659,559